
═══════════════════════════════════════════════════════════════════════════════
Table X. Pathway Activity Across HBV Infection Stages
═══════════════════════════════════════════════════════════════════════════════

Mean pathway activity scores calculated for each disease stage using single-cell
gene expression data from 243,000 cells (GSE182159). Statistical significance
tested using Mann-Whitney U test (IT vs NL).

─────────────────────────────────────────────────────────────────────────────────
Pathway                    | IT vs NL Direction | p-value      | Interpretation
─────────────────────────────────────────────────────────────────────────────────
mTOR_signaling            | IT > NL (↑)        | 9.68e-108    | Compensatory mTOR activation
                          |                     |              | in response to metabolic stress
─────────────────────────────────────────────────────────────────────────────────
glycolysis                | IT < NL (↓)        | 2.37e-13     | Impaired glycolytic metabolism
                          |                     |              | consistent with NK dysfunction
─────────────────────────────────────────────────────────────────────────────────
oxidative_phosphorylation | IT > NL (↑)        | <1e-300      | Mitochondrial stress signature
                          |                     |              | (Mito-high clusters 21, 23)
─────────────────────────────────────────────────────────────────────────────────
nk_cell_cytotoxicity      | IT < NL (↓)        | <1e-300      | NK cell functional collapse
                          |                     |              | supporting immune tolerance
─────────────────────────────────────────────────────────────────────────────────
il15_signaling            | IT > NL (↑)        | 4.09e-30     | Altered IL-15 signaling axis
                          |                     |              | (HBsAg-IL15Rβ interaction)
─────────────────────────────────────────────────────────────────────────────────
b_cell_differentiation    | IT > NL (↑)        | 2.59e-09     | B cell maturation arrest
                          |                     |              | (Naive B accumulation)
─────────────────────────────────────────────────────────────────────────────────

Key Findings:

1. OXIDATIVE PHOSPHORYLATION (OXPHOS)
   - Dramatically elevated in IT phase (Z-score: +0.97)
   - Reflects mitochondrial stress in IT-exclusive clusters (21, 23)
   - Indicates metabolic reprogramming during immune tolerance

2. NK CELL CYTOTOXICITY  
   - Markedly reduced in IT phase compared to NL (Z-score: NL +1.48 → IT +0.07)
   - Confirms NK cell functional collapse as hallmark of IT phase
   - Supports HBsAg-mediated NK suppression hypothesis

3. GLYCOLYSIS
   - Reduced in IT phase relative to NL
   - Consistent with impaired metabolic function in tolerant immune cells
   - Links to mTOR-glycolysis axis dysfunction (Yu et al. 2025)

4. mTOR SIGNALING
   - Elevated in IT phase
   - May represent compensatory response to metabolic stress
   - Key node in HBsAg-IL15Rβ-mTOR pathway

Clinical Implications:
- Pathway signatures can distinguish IT phase from other disease stages
- OXPHOS and NK cytotoxicity are most discriminative markers
- Potential therapeutic targets: mTOR modulators, metabolic enhancers

Reference: Yu Y, et al. Cell Death Dis. 2025 - HBsAg/IL-15Rβ/mTOR axis
═══════════════════════════════════════════════════════════════════════════════
